Study on Maintaining Remission in ANCA-Associated Vasculitis with Prednisone and Rituximab for Patients in Remission from Granulomatosis with Polyangiitis or Microscopic Polyangiitis

Registered drug

Study on Maintaining Remission in ANCA-Associated Vasculitis with Prednisone and Rituximab for Patients in Remission from Granulomatosis with Polyangiitis or Microscopic Polyangiitis

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Prednisone
Sponsor:Hospices Civils De Lyon

Contact Research Centre

Epidermolysis bullosa

Recruiting

Study on the Effectiveness and Safety of Apremilast for Patients Aged 6 and Older with Generalized Epidermolysis Bullosa Simplex

Registered drugNo placebo

Study on the Effectiveness and Safety of Apremilast for Patients Aged 6 and Older with Generalized Epidermolysis Bullosa Simplex

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Apremilast
Sponsor:Centre Hospitalier Universitaire De Nice

Contact Research Centre

Gastrooesophageal cancer+3

Recruiting

Study of Oxaliplatin, Nivolumab, and Trifluridine/Tipiracil for Patients with Advanced Gastric, Esophageal, or Gastroesophageal Junction Cancer

Registered drugNo placebo

Study of Oxaliplatin, Nivolumab, and Trifluridine/Tipiracil for Patients with Advanced Gastric, Esophageal, or Gastroesophageal Junction Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Unicancer

Contact Research Centre

Myotonic dystrophy

Recruiting

Study on the Effects of Metformin for Improving Muscle Function in Patients with Myotonic Dystrophy Type 1

Registered drug

Study on the Effects of Metformin for Improving Muscle Function in Patients with Myotonic Dystrophy Type 1

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Metformin Hydrochloride
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Thyroid cancer+2

Recruiting

Study Comparing Two Treatment Strategies for Intermediate-Risk Thyroid Cancer Using Sodium Iodide (131I) in Patients with Post-Surgery Evaluation

Registered drugNo placebo

Study Comparing Two Treatment Strategies for Intermediate-Risk Thyroid Cancer Using Sodium Iodide (131I) in Patients with Post-Surgery Evaluation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Sodium iodide (131I)
Sponsor:Centre Francois Baclesse

Contact Research Centre

Ovarian cancer

Recruiting

Study of Paclitaxel, Carboplatin, and Bevacizumab with Niraparib for Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer After Surgery

Registered drugNo placebo

Study of Paclitaxel, Carboplatin, and Bevacizumab with Niraparib for Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer After Surgery

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:Arcagy Gineco

Contact Research Centre

Epstein-Barr virus infection+1

Recruiting

Study on Rituximab for Preventing Epstein-Barr Virus Infection and Lymphoproliferative Disorders in EBV-Negative Kidney Transplant Patients

Registered drugNo placebo

Study on Rituximab for Preventing Epstein-Barr Virus Infection and Lymphoproliferative Disorders in EBV-Negative Kidney Transplant Patients

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Rituximab
Sponsor:Les Hopitaux Universitaires De Strasbourg

Contact Research Centre

Other cities in France

The busiest research cities in the country

All 382 cities in France

Clinical research in Brest

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials focusing on head and neck squamous cell carcinoma, exploring innovative treatments combining radiotherapy with targeted therapies. Studies also examine new approaches for esophageal cancer and pancreatic adenocarcinoma.

Advanced Cancer Therapies
Combination Treatments
Targeted Therapeutics

Multiple trials are investigating novel drug combinations and immunotherapy approaches for various cancer types.

02 Autoimmune Conditions

Comprehensive research into Sjögren's syndrome treatment options, including innovative biological therapies and histopathological studies. Additional focus on rheumatoid arthritis and novel therapeutic approaches.

Biological Treatments
Disease Mechanisms
Treatment Response

Studies aim to understand disease mechanisms and evaluate new therapeutic options for autoimmune disorders.

03 Cardiovascular and Respiratory Studies

Investigation of treatments for pulmonary arterial hypertension and heart failure prevention. Research includes innovative drug combinations and preventive approaches for cardiovascular conditions.

Heart Failure Prevention
Hypertension Management
Asthma Control

Focus on developing effective treatments for chronic cardiovascular and respiratory conditions.

Back to France All countries